CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE PCR QUALITATIVE Test
At DNA Labs UAE, we offer the CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE PCR QUALITATIVE Test at a cost of AED 1100.0. This test is used to detect the presence of Chlamydia trachomatis and Neisseria gonorrhoeae in a patient’s sample.
Test Components
Price: AED 1100.0
Sample Condition
15 ml (8 mL min.) preferably first morning urine in a sterile screw capped container OR Vaginal / Endocervical/ Conjuctival swab in normal saline. Ship refrigerated or frozen.
Report Delivery
Sample Daily by 11 am; Report Next day
Method
Real Time PCR
Test Type
Infections
Doctor
Physician, Gynecologist
Test Department
MOLECULAR DIAGNOSTICS
Pre Test Information
First morning urine sample preferred.
Test Details
The Chlamydia trachomatis and Neisseria gonorrhoeae PCR qualitative test is a diagnostic test used to detect the presence of Chlamydia trachomatis and Neisseria gonorrhoeae in a patient’s sample. PCR stands for polymerase chain reaction, which is a molecular technique that amplifies specific DNA sequences.
In this test, the PCR technique is used to amplify and detect the DNA of Chlamydia trachomatis and Neisseria gonorrhoeae, two common sexually transmitted infections. The test is qualitative, meaning it provides a yes or no answer regarding the presence of the pathogens.
If the DNA of Chlamydia trachomatis or Neisseria gonorrhoeae is detected in the patient’s sample, the test result will be positive. If no DNA is detected, the test result will be negative.
This test is commonly performed using a swab sample from the urethra, cervix, rectum, or throat, depending on the suspected site of infection. The sample is then sent to a laboratory where the PCR technique is used to detect the DNA of Chlamydia trachomatis and Neisseria gonorrhoeae.
The Chlamydia trachomatis and Neisseria gonorrhoeae PCR qualitative test is highly sensitive and specific, meaning it can accurately detect the presence or absence of these pathogens. It is considered the gold standard for diagnosing these infections and is recommended by healthcare professionals for screening and diagnosis.
Test Name | CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE PCR QUALITATIVE Test |
---|---|
Components | |
Price | 1100.0 AED |
Sample Condition | 15 ml (8 mL min.) preferably first morning urine in a sterile screw capped container OR Vaginal \/ Endocervical\/ Conjuctival swab in normal saline. Ship refrigerated or frozen. |
Report Delivery | Sample Daily by 11 am; Report Next day |
Method | Real Time PCR |
Test type | Infections |
Doctor | Physician, Gynecologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | First morning urine sample preferred. |
Test Details |
The Chlamydia trachomatis and Neisseria gonorrhoeae PCR qualitative test is a diagnostic test used to detect the presence of Chlamydia trachomatis and Neisseria gonorrhoeae in a patient’s sample. PCR stands for polymerase chain reaction, which is a molecular technique that amplifies specific DNA sequences. In this test, the PCR technique is used to amplify and detect the DNA of Chlamydia trachomatis and Neisseria gonorrhoeae, two common sexually transmitted infections. The test is qualitative, meaning it provides a yes or no answer regarding the presence of the pathogens. If the DNA of Chlamydia trachomatis or Neisseria gonorrhoeae is detected in the patient’s sample, the test result will be positive. If no DNA is detected, the test result will be negative. This test is commonly performed using a swab sample from the urethra, cervix, rectum, or throat, depending on the suspected site of infection. The sample is then sent to a laboratory where the PCR technique is used to detect the DNA of Chlamydia trachomatis and Neisseria gonorrhoeae. The Chlamydia trachomatis and Neisseria gonorrhoeae PCR qualitative test is highly sensitive and specific, meaning it can accurately detect the presence or absence of these pathogens. It is considered the gold standard for diagnosing these infections and is recommended by healthcare professionals for screening and diagnosis. |